Tag Archives: drug

So far, so not-so-good: Neurologists slow to warm up to Biogen’s Alzheimer drug Aduhelm, study finds

Neurologists are thinking about Biogen’s newly approved Alzheimer’s drug, but so far it’s mostly just that—thoughts. While almost 90% of neurologists are moderately or highly aware of Aduhelm, only 3% have written prescriptions so far, according to Spherix Global Insights latest data. Even more concerning? Only about one fourth (27%) plan to prescribe the drug in… Read More »

Biogen Alzheimer’s drug and the battle over dementia treatment of the future

Aduhelm by Biogen Source: Biogen The FDA’s approval of Biogen‘s Alzheimer’s drug Aduhelm was a landmark moment in the life of Dr. Paul Aisen. The director of the Alzheimer’s Therapeutic Research Institute at USC has spent the past three decades focused on treating the neurodegenerative disease, and in recent years helped shepherd this particular drug… Read More »

How to Choose the Right Place for Alcohol or Drug Rehab

SOURCES: Margaret A. E. Jarvis, MD, DFASAM, chief of addiction services, Geisinger Addiction Medicine; Geisinger Neuroscience Institute, Mechanicsville, PA. Paul H. Earley, MD, DFASAM, immediate past president, American Society of Addiction Medicine, College Park, GA. Marvin Ventrell, JD, chief executive officer, National Association of Addiction Treatment Providers, Denver, CO. The American Journal of Psychiatry: “DSM-5… Read More »

Johnson & Johnson snares FDA nod for first exon 20-targeted drug in EGFR lung cancer

Just a few short months after Johnson & Johnson’s Janssen unit sent its targeted non-small cell lung cancer (NSCLC) drug amivantamab to the FDA, the regulator has come back with a green light—a very specific one. Now christened Rybrevant, the drug is the first treatment for NSCLC with a group of epidermal growth factor receptor (EGFR) mutations found in… Read More »